Clinical Trial: AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors

U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770243) titled 'AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors' on May 03.

Brief Summary: This pilot randomized controlled trial will test the feasibility and acceptability of an Artificial Intelligence-based Multidimensional Symptom Management (AIMS) intervention for post-treatment breast cancer survivors. Thirty-six participants will be randomly assigned (1:1) to receive either the AIMS intervention or usual care. Outcomes include feasibility (recruitment and retention), adherence, acceptability, symptom burden, psychological distress, quality of life, and safety of the AIMS intervention.

Study Start Date: Aug. 10

Study ...